Antiglucocorticoid therapy for the prevention of neurological damage in premature infants

Details for Australian Patent Application No. 2004258992 (hide)

Owner Corcept Therapeutics, Inc.

Inventors Belanoff, Joseph K.

Agent FB Rice

Pub. Number AU-B-2004258992

PCT Pub. Number WO2005/009382

Priority 60/489,601 23.07.03 US

Filing date 22 July 2004

Wipo publication date 3 February 2005

Acceptance publication date 25 November 2010

International Classifications

A61K 31/235 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/567 (2006.01) - substituted in position 17 alpha, e.g. mestranol, norethandrolone

A61K 31/569 (2006.01)

A61K 31/573 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/009382 Priority application(s): WO2005/009382

25 November 2010 Application Accepted

  Published as AU-B-2004258992

24 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004258998-Systems and methods for assessing disorders affecting fine motor skills using handwriting recognition

2004258985-Methods for fabricating cellular cushions